Publications

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

AuthID
P-009-E3Y

Author(s)

Natkunam, Y

Farinha, P

Hsi, ED

Hans, CP

Tibshirani, R

Sehn, LH

Connors, JM

Gratzinger, D

Rosado, M

Zhao, S

Pohlman, B

Wongchaowart, N

Bast, M

Avigdor, A

Schiby, G

Nagler, A

Byrne, GE

Levy, R

Gascoyne, RD

Lossos, IS

Document Type

Article

Year published

2008

Published

in Journal of Clinical Oncology, ISSN: 0732-183X

Volume: 26, Issue: 3, Pages: 447-454

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2007.13.0690

Pubmed: 18086797

SCOPUS: 2-s2.0-38649123973

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

Useful Links

Get Help

Federated Authentication (Click on the image)

Lmo2 Protein Expression Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline-Based Chemotherapy with and Without Rituximab

Useful Links

Get Help